1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
1 |
| Hold |
1 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | 2022 | |
|---|---|---|
| Revenue | 1,18M | 24,56% |
| Gross profit | −5,35M | 345,79% |
| Net profit | −54,81M | 215,29% |
| EBITDA | −33,17M | 21,46% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | 0,00€ |
52-week high/low | 2,98€ - 0,0118€ |
| Dividends | No |
Beta | 1,58 |
P/E ratio | 0,00 |
PEG ratio | 0,00 |
P/B ratio | 0,00 |
P/S ratio | 0,00 |
Company profile
| Name | BAUDAX BIO INC.(WI)DL-,01 |
| CEO | Geraldine A. Henwood |
| Headquarters | Malvern,
pa USA |
| Employees | 9 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | BXRX |
Discover assets
Shareholders of BAUDAX BIO INC.(WI)DL-,01 also invest in the following assets
